Drugs / Fluzone Intradermal Quadrivalent
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02563093 | Sep → Dec 2015 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzone Intradermal Quadrivalent | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02563093 ↗ |
| Known as | Fluzone Intradermal Quadrivalent, Influenza Vaccine | “Fluzone® Intradermal Quadrivalent, Influenza Vaccine” NCT02563093 ↗ |
| Modality | Vaccine | “Influenza Vaccines” NCT02563093 ↗ |
| Route | Other | “0.1 mL, Intradermal” NCT02563093 ↗ |